BioSpace News Archive

Champions Oncology, Inc. will report its financial and operational results for the third quarter ended January 31, 2023, on Wednesday, March 15, 2023, after market close.

Heron Therapeutics, Inc. today announced that CMS has approved transitional pass-through status for APONVIE.

Therapeutic Solutions International (TSOI) announced today new data and filing of a patent covering the discovery that JadiCell therapeutic activity in a model of Chronic Obstructive Pulmonary Disease (COPD) can be transferred to naïve animals by a specialized type of B cell.

Lantern Pharma Inc., a clinical-stage biopharmaceutical company using its proprietary RADR® artificial intelligence and machine learning platform to transform the cost, pace, and timeline of oncology drug discovery and development, announced that neither Lantern Pharma Inc. nor any of its subsidiaries had any exposure to Silicon Valley Bank, Silvergate Bank, or Signature Bank.

ITM Isotope Technologies Munich SE, a leading radiopharmaceutical biotech company, Helmholtz Munich and the Departments of Neurosurgery and Nuclear Medicine at the University Hospital Münster announced the start of a Phase I clinical trial with ITM’s drug candidate ITM-31, a novel Targeted Radionuclide Therapy candidate for the treatment of malignant glioblastoma.

Protalix BioTherapeutics, Inc. announced today that it does not hold cash deposits or securities at either Silicon Valley Bank or Signature Bank, nor does it have any credit facility or other financial relationship with either institution.

ALX Oncology Holdings Inc. and Quantum Leap Healthcare Collaborative (“Quantum Leap”) today announced that the first patient has been dosed in the I-SPY-P1-TRIAL for the treatment of patients with unresectable or metastatic HER2-positive and HER2-low breast cancer.

HOOKIPA Pharma Inc. announced today that Terry Coelho will join its Board of Directors, Audit Committee and Compensation Committee, effective April 3, 2023.

Outlook Therapeutics, Inc. today announced that it is aware that the Federal Deposit Insurance Corp. has taken control of Silicon Valley Bank (“SVB”).

Thorne HealthTech, Inc. today announced that it has appointed Saloni Varma as Chief Financial Officer (CFO).